Lysophosphatidic acid, a blood-borne lipid mediator that is elevated in the ascites of ovarian cancer patients, has been shown to up-regulate HK2 and glycolysis, leading to enhanced proliferation of ovarian cancer cells [42]. This evidence concerns the gene HK2 and ovarian cancer.